PURDUE PHARMA LTD has a total of 11 patent applications. Its first patent ever was published in 1994. It filed its patents most often in EPO (European Patent Office), Argentina and Brazil. Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are SAGE THERAPEUTICS INC, KLEMKE RUDOLF ERICH and SOFT DRUGS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 2 | |
#2 | Argentina | 1 | |
#3 | Brazil | 1 | |
#4 | Canada | 1 | |
#5 | China | 1 | |
#6 | Czechia | 1 | |
#7 | Israel | 1 | |
#8 | Mexico | 1 | |
#9 | New Zealand | 1 | |
#10 | Poland | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Steroids | |
#3 | Medical preparations |
# | Name | Total Patents |
---|---|---|
#1 | Hogenkamp Derk J | 5 |
#2 | Hogenkamp Derk L | 3 |
#3 | Howard Stephen A | 1 |
#4 | Bolger Michael B | 1 |
#5 | Tahir Hasan | 1 |
#6 | Reidenberg Bruce | 1 |
#7 | Upasani Ravindra B | 1 |
#8 | Purdy Robert | 1 |
#9 | Lan Nancy Tsai-Yun | 1 |
#10 | Gee Kelvin W | 1 |
Publication | Filing date | Title |
---|---|---|
CN1780611A | Tamper-resistant transdermal dosage form comprising an active agent component and an adverse agent component at the distal site of the active agent layer | |
EP1177206A1 | 3alpha-hydroxy-3beta methoxymethyl-21-heterocycle substituted steroids with anaesthetic activity |